Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use

Abstract Background Oral polio vaccine (OPV) containing attenuated serotype 2 polioviruses was globally withdrawn in 2016, and bivalent OPV (bOPV) containing attenuated serotype 1 and 3 polioviruses needs to be withdrawn after the certification of eradication of all wild polioviruses to eliminate fu...

Full description

Bibliographic Details

Published in:	BMC Infectious Diseases
Main Authors:	Radboud J. Duintjer Tebbens, Lee M. Hampton, Kimberly M. Thompson
Format:	Article
Language:	English
Published:	BMC 2018-04-01
Subjects:	Polio Eradication Risk management Oral poliovirus vaccine Dynamic modeling Vaccine-derived poliovirus
Online Access:	http://link.springer.com/article/10.1186/s12879-018-3074-0